GENPHARMASEC
Quarterly Results Analysis [Jun2025]
GENPHARMASEC Quarterly Results
| Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹12 Cr | ₹14 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr | ₹6 Cr | ₹8 Cr |
| Expenses | ₹11 Cr | ₹15 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹10 Cr | ₹6 Cr | ₹8 Cr |
| Operating Income | ₹1 Cr | ₹-1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Profit Before Tax | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Profit After Tax | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | ₹0.02 | ₹0.00 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.00 | ₹0.00 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GENPHARMASEC | NA | -11.5% | -37.5% |
| SUDARSHAN CHEMICAL INDUSTRIES | -3.5% | -21.4% | 20.1% |
| KIRI INDUSTRIES | -1% | -4.4% | 53.3% |
| VIDHI SPECIALTY FOOD INGREDIENTS | -3.4% | -7.7% | -25.3% |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | 3.3% | -8.4% | 54.6% |
| BODAL CHEMICALS | 2.2% | -6.8% | -25.1% |
| BHAGERIA INDUSTRIES | 36.7% | 30.9% | 9.8% |
| DYNEMIC PRODUCTS | 3.3% | -11.2% | -25.6% |
| PODDAR PIGMENTS | 1.2% | -4.2% | -29.2% |
GENPHARMASEC Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -14.04 % |
| Y-o-Y | 131.82 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2025 | ₹12 Cr | -14.04 | |
| Mar2025 | ₹14 Cr | 65.13 | |
| Dec2024 | ₹8 Cr | 40.63 | |
| Sep2024 | ₹6 Cr | 16.13 | |
| Jun2024 | ₹5 Cr | -49.06 | |
| Mar2024 | ₹10 Cr | 59.73 | |
| Dec2023 | ₹6 Cr | -18.76 | |
| Sep2023 | ₹8 Cr | - | |
GENPHARMASEC Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | 427.53 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2025 | ₹1 Cr | Positive | |
| Mar2025 | ₹-1 Cr | Negative | |
| Dec2024 | ₹1 Cr | 475.00 | |
| Sep2024 | ₹0 Cr | -28.09 | |
| Jun2024 | ₹0 Cr | Positive | |
| Mar2024 | ₹0 Cr | Negative | |
| Dec2023 | ₹0 Cr | Positive | |
| Sep2023 | ₹0 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | 127.41 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2025 | 7.8% | Positive | |
| Mar2025 | -7.13% | Negative | |
| Dec2024 | 8.68% | 309.43 | |
| Sep2024 | 2.12% | -38.19 | |
| Jun2024 | 3.43% | Positive | |
| Mar2024 | -0.13% | Negative | |
| Dec2023 | 0.27% | Positive | |
| Sep2023 | -0.53% | - | |
GENPHARMASEC Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | 323.00 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2025 | ₹1 Cr | Positive | |
| Mar2025 | ₹0 Cr | Negative | |
| Dec2024 | ₹1 Cr | 10.80 | |
| Sep2024 | ₹1 Cr | 145.30 | |
| Jun2024 | ₹0 Cr | -41.31 | |
| Mar2024 | ₹0 Cr | 676.19 | |
| Dec2023 | ₹0 Cr | 950.00 | |
| Sep2023 | ₹0 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | 82.61 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2025 | 10.08 % | Positive | |
| Mar2025 | -1.93 % | Negative | |
| Dec2024 | 9.19 % | -21.25 | |
| Sep2024 | 11.67 % | 111.41 | |
| Jun2024 | 5.52 % | 15.24 | |
| Mar2024 | 4.79 % | 383.84 | |
| Dec2023 | 0.99 % | 1,137.50 | |
| Sep2023 | 0.08 % | - | |
GENPHARMASEC Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 0 |
| Y-o-Y | 100.00 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2025 | ₹0.02 | 0 | |
| Mar2025 | ₹0 | -100.00 | |
| Dec2024 | ₹0.01 | 0.00 | |
| Sep2024 | ₹0.01 | 0.00 | |
| Jun2024 | ₹0.01 | 0.00 | |
| Mar2024 | ₹0.01 | 0 | |
| Dec2023 | ₹0 | 0 | |
| Sep2023 | ₹0 | - | |
You may also like the below Video Courses